DFLers were surprised by Republican Sen. Michelle Benson’s move to amend her own bill to include the benefit.
It’s a troubling trend, write the study’s authors, because it means “the gap between educational and promotional content within the advertisements has increased.”
Three experts point out that not only does drug deregulation put more people’s health at risk (not just in the U.S., but around the world), it also serves as a drain on the economy.
Afinitor, for example, has been shown to delay the growth, or progression, of tumors by a few months, but it has not been shown to help people live longer, an investigative report finds.
A chaplain in Philadelphia said: “These guys have no job, no home, and a [illegal drug] habit. You have people at their lowest state, and they’ll say yes to anything.”
Direct-to-consumer marketing of drugs is prohibited in the U.K. — a likely key factor behind the countries’ differences, say researchers.
“Drug companies have turned into marketing machines,” Dr. Thomas Marciniak said. “They’ve kind of lost sight of the fact that they’re actually doing something which involves your health.”
Low testosterone is “in large part an invented condition,” and commercials for “low-T” gels, patches and other products are simply playing on older men’s fears about aging.
Six out of 10 claims made in those commercials are misleading and one in 10 are downright false, according to a study in the Journal of General Internal Medicine.
The controversy over the safety of the diabetes drugs known as incretin therapies escalated with a new investigative report by British reporters.
The campaign is “a mass, uncontrolled experiment that invites men to expose themselves to the harms of a treatment unlikely to fix problems that may be wholly unrelated to testosterone levels,” two doctors write.
This finding has important significance for health consumers, including those who rely on information recommended to them by their physicians.
“What sets this author apart from most other writers is his charisma, his energy, and his unfiltered comic bluntness,” writes the U of M’s Dr. Carl Elliott.
“There remains substantial uncertainty about whether this drug is worth taking,” concludes Dr. Harlan Krumholz of Yale University School of Medicine.
The governments of many countries, including the United States, have spent billions of dollars stockpiling the drug for use in a pandemic.
“Bad Pharma” takes aim at how the pharmaceutical industry uses scientific tricks and shenanigans to push its products.
Boston University law professor Kevin Outterson points out that the settlements have little impact on the profits of the companies involved.